Ethinylestradiol + cyproterone: back in France for acne and hirsutism, despite frequent off-label prescription
Prescrire International 23(151): 183
2014
ISSN/ISBN: 1167-7422 PMID: 25162092 Document Number: 672255
Following a European review, products containing the ethinylestradiol + cyproterone combination are back on the French market for women with acne (as second-line treatment) or hirsutism. Yet experience has shown that frequent off-label prescription of this combination for contraceptive purposes exposes many women to an unjustified risk of thromboembolism.
Document emailed within 1 workday
Related Documents
Nardi, M.; De Aloysio, D.; Busacchi, P.; Flamigni, C. 1975: Cyproterone acetate - ethinylestradiol treatment of hirsutism, acne, seborrhea and alopecia Acta Europaea Fertilitatis 6(2): 153-165Sanam, M.; Ziba, O. 2011: Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. which one has better affect on acne, hirsutism, and weight change Saudi Medical Journal 32(1): 23-26
Chabbert-Buffet, N.; Amy, J-Jacques. 2013: The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified? European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 18(2): 75-78
Fraser, I.S.; Shearman, R.P.; Allen, J.K.; McCarron, G. 1983: Cyproterone acetate and the treatment of hirsutism Australian and New Zealand Journal of Obstetrics and Gynaecology 23(2): 93-98
Baron, J.; Chwalisz, K.; Warenik-Szymankiewicz, A. 1982: Value of cyproterone acetate in the treatment of hirsutism Ginekologia Polska 53(4): 283-287
Paggi, A.; Leri, O.; Parrettini, S.; Di Meo, G.; Corsi, V. 1981: A short clinical trial of cyproterone acetate in the treatment of idiopathic hirsutism La Clinica Terapeutica 96(4): 443-453
Holdaway, I.M.; Croxson, M.S.; Evans, M.C.; France, J.; Sheehan, A.; Wilson, T.; Ibbertson, H.K. 1983: Effect of cyproterone acetate on glucocorticoid secretion in patients treated for hirsutism Acta Endocrinologica 104(2): 222-226
Leo-Rossberg, I.; Laur, S.; Zielske, F.; Hammerstein, J. 1971: Reversed sequential therapy of hirsutism using cyproterone acetate. I. Further clinical observations Acta Endocrinologica. Supplementum 152: 14
Porcile, A.; Gallardo, E. 1991: Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives Fertility and Sterility 55(5): 877-881
Garner, P.R.; Poznanski, N. 1984: Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen Journal of Reproductive Medicine 29(4): 232-236
Villaseca, P.; Hormaza, P.; Cárdenas, I.; Oestreicher, E.; Arteaga, E. 2004: Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 9(3): 155-165
Audebert, A.; Emperaire, J.C.; Gauthier, A.; Hallonet, P.; Hedon, B.; Lopes, P.; Quereux, C.; Roulier, R. 1991: Multicentric clinical trial of a combination of 35 micrograms of ethinylestradiol and 2 mg of cyproterone acetate Revue Francaise de Gynecologie et d'Obstetrique 86(11): 697-699
Van Vloten, W.A.; van Haselen, C.W.; van Zuuren, E.J.; Gerlinger, C.; Heithecker, R. 2002: The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea Cutis 69(4 Suppl): 2-15
Nazli, Y.; Colak, N.; Aksoy, O.N.; Cakir, O. 2011: Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 22(4): 331-333
Vartiainen, M.; de Gezelle, H.; Broekmeulen, C.J. 2001: Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 6(1): 46-53
Zhang, C.; Li, H.; Xiong, X.; Zhai, S.; Wei, Y.; Zhang, S.; Zhang, Y.; Xu, L.; Liu, L. 2017: An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch Drug Design Development and Therapy 11: 725-731
McKean, A.; Monasterio, E.; Elliott, T. 2018: How common is off-label prescription of quetiapine? New Zealand Medical Journal 131(1484): 77-78
Carlborg, L. 1986: Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Results of a multicenter study Acta Obstetricia et Gynecologica Scandinavica. Suppl 134: 29-32
Heger-Mahn, D.; Warlimont, C.; Faustmann, T.; Gerlinger, C.; Klipping, C. 2004: Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 9(3): 173-181
Strowitzki, T.; Kirsch, B.; Elliesen, J.ör. 2012: Efficacy of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study Journal of Family Planning and Reproductive Health Care 38(2): 94-101